Health-related quality of life after adverse bleeding events associated with antithrombotic drug therapy - A systematic review.
作者： Lodewijk C.S. Res , Bart Lubberts , Shivesh H. Shah , Christopher W. DiGiovanni
DOI: 10.1016/J.HJC.2018.06.012
关键词:
摘要: Abstract Little is known about the health-related quality of life (HRQOL) following adverse bleeding events associated with antithrombotic drug therapy. This systematic review assesses HRQOL patients who suffered a event related to use. A literature search was performed using PubMed, EMBASE, and Cochrane Library from inception through June 16, 2017. Studies measuring after therapy for primary or secondary prevention thromboembolic were included. Four studies total 13,209 met inclusion criteria, them, 3,649 developed event. Patients included received drugs because acute myocardial infarction atrial fibrillation. EQ-5D, SF-36, GHP MOS-13 used measure HRQOL. The follow-up time ranged 6 29 months. reported worse compared those did not (EQ-5D – average increase on all domains 0.09, p-values ranging
narcis.nl参考文章(91)
Thomas Wilke, Patient Preferences for an Oral Anticoagulant after Major Orthopedic Surgery The Patient: Patient-Centered Outcomes Research. ,vol. 2, pp. 39- 49 ,(2009) , 10.2165/01312067-200902010-00005
Maria Victoria Zunzunegui, Nadia Minicuci, Tzuia Blumstein, Marianna Noale, Dorly Deeg, Marja Jylhä, Nancy L. Pedersen, , Gender differences in depressive symptoms among older adults: a cross-national comparison Social Psychiatry and Psychiatric Epidemiology. ,vol. 42, pp. 198- 207 ,(2007) , 10.1007/S00127-007-0158-3
Jeffrey A Kline, Jackeline Hernandez, Melanie M Hogg, Alan E Jones, D Mark Courtney, Christopher Kabrhel, Kristen E Nordenholz, Deborah B Diercks, Matthew T Rondina, James R Klinger, Rationale and methodology for a multicentre randomised trial of fibrinolysis for pulmonary embolism that includes quality of life outcomes. Emergency Medicine Australasia. ,vol. 25, pp. 515- 526 ,(2013) , 10.1111/1742-6723.12159
Mehrdad Sheikhvatan, Mahmood Shirzad, Mehrab Marzban, Abbasali Karimi, Kyomars Abbasi, Abbas Salehi Omran, Seyed Hossein Ahmadi, Namvar Movahhedi, Saeed Davoodi, Short- and mid-term results of triple-valve surgery with an evaluation of postoperative quality of life. Texas Heart Institute Journal. ,vol. 36, pp. 125- 130 ,(2009)
Mirjam Sprangers, Hanneke de Haes, Harry Büller, Martin Prins, Mirjam Locadia, Quality of life and the duration of treatment with vitamin k antagonists in patients with deep venous thrombosis Thrombosis and Haemostasis. ,vol. 90, pp. 101- 107 ,(2003) , 10.1055/S-0037-1613605
Marilyn Bergner, Ruth A. Bobbitt, William B. Carter, Betty S. Gilson, The Sickness Impact Profile: development and final revision of a health status measure. Medical Care. ,vol. 19, pp. 787- 805 ,(1981) , 10.1097/00005650-198108000-00001
Ehab Elzayat, Enmar Habib, Mostafa Elhilali, Holmium Laser Enucleation of the Prostate in Patients on Anticoagulant Therapy or With Bleeding Disorders The Journal of Urology. ,vol. 175, pp. 1428- 1432 ,(2006) , 10.1016/S0022-5347(05)00645-2
J. A. Kline, K. E. Nordenholz, D. M. Courtney, C. Kabrhel, A. E. Jones, M. T. Rondina, D. B. Diercks, J. R. Klinger, J. Hernandez, Treatment of submassive pulmonary embolism with tenecteplase or placebo: Cardiopulmonary outcomes at 3 months: Multicenter double-blind, placebo-controlled randomized trial Journal of Thrombosis and Haemostasis. ,vol. 12, pp. 459- 468 ,(2014) , 10.1111/JTH.12521
Janel Hanmer, William F. Lawrence, John P. Anderson, Robert M. Kaplan, Dennis G. Fryback, Report of nationally representative values for the noninstitutionalized US adult population for 7 health-related quality-of-life scores. Medical Decision Making. ,vol. 26, pp. 391- 400 ,(2006) , 10.1177/0272989X06290497
Tim R. Lancaster, The Impact of Long-term Warfarin Therapy on Quality of Life Archives of Internal Medicine. ,vol. 151, pp. 1944- 1949 ,(1991) , 10.1001/ARCHINTE.1991.00400100032005